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Abstract
Purpose: The quadrivalent HPV vaccination was approved for use in males ages 9
to 26 in 2009 and recommended for routine administration in 2011. The purpose of
this study was to uncover predictable commonalities amongst parents who chose to
vaccinate their 11–17 year old sons against HPV.
Methods: We compiled data from a U.S. national sample of 779 parents with sons
11–17 years old using a web-based survey to gather information about behavioral
and sociodemographic factors which predicted receipt of 1 or more HPV vaccine
doses based on parental report. Predictors were first modeled individually for
univariable associations. Significant predictors (p,0.10) were combined in a
multivariable model.
Results: In the adjusted model, independent predictors included receipt of flu
vaccination, health insurance coverage and sexual health topic discussions with
sons. Sons who had received a flu shot in the last two years more frequently
received at least one dose of the vaccine (OR 1.82; 95% CI 1.45–2.26). Sons
covered by private health insurance had decreased odds of HPV vaccination (OR
0.56 95% CI 0.37–0.83). Lastly, parents who had discussed sexual health topics
with their sons were more likely to vaccinate (OR 1.61; 95% CI 1.37–1.89).
Conclusions: Male vaccination rates in the U.S. have increased, but males
continue to be under-immunized. Utilization of health care is an important factor in
HPV vaccine uptake; therefore, health care providers should use every contact as
an opportunity to vaccinate. Communication about sexual health topics may
provide a forum for parents and health care providers to have conversations about
HPV vaccination as those more comfortable discussing these topics may also be
more comfortable discussing HPV vaccination.
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Introduction
Human papillomavirus (HPV) is the most common sexually transmitted
infection. [1] There are known causal associations between HPV and genital and
anal cancers as well as genital warts and cancers of the head and neck. [2] The
quadrivalent HPV vaccination protects against the most common HPV strains
that cause HPV-related diseases: 6, 11, 16, and 18. It was approved for use in
females in 2006 and, in 2009, it was approved for use in males ages 9 to 26. The
recommendation for routine administration in males came in 2011. [3] Despite
these recommendations, vaccination rates remain low. The most recent U.S
National Immunization Survey-Teen (NIS-TEEN) data on adolescent vaccination
indicates that 53.8% of females and 20.8% of males received at least one dose of
HPV vaccine. [4] The NIS-TEEN collects data by list-assisted random-digit-
dialing telephone survey followed by a mailed survey to children’s immunization
providers [5].
The approval for use and consistent recommendations for HPV vaccination in
males followed those for females, therefore, most research to date has
concentrated on females. This research has focused largely on predictors of
acceptability (i.e. attitudes surrounding vaccination and/or intention to vaccinate)
and uptake (i.e. the actual act of getting the vaccine) [6] whereas most existing
research regarding vaccination among males has focused solely on vaccine
acceptability, largely because the recommendation to routinely vaccinate males is
relatively recent.
Research published on females has suggested that parents who have previously
vaccinated their adolescent daughters against HPV have more favorable attitudes
toward HPV vaccine use in males. [7] Consistent with female vaccination data
[8, 9], parents who consider religion more important are less willing to vaccinate
their sons. [7] Parents who were more comfortable discussing new vaccines with
their sons, and those with more liberal political views, were also more accepting of
the HPV vaccine. [10] Additionally, it has been shown that males who have been
vaccinated with other adolescent-timed vaccines, specifically the meningococcal
vaccine, are more likely to have initiated the HPV vaccine [11], which is consistent
with previous literature on female vaccination [12].
In one of the few studies published on HPV vaccine uptake in males, males
whose mothers have received the influenza vaccine and pap smears are more likely
to have been vaccinated. [13] Reiter et al showed that fathers are less likely than
mothers to vaccinate and that health care provider (HCP) recommendation
predicted vaccine uptake in males, similar to findings in adolescent females. [14]
While vaccine uptake in males continues to increase, the percentage of males
vaccinated remains low. There is currently insufficient data on predictors of male
vaccine initiation. A recently published paper based on this dataset explored
parents’ reported reasons for non-vaccination of sons. [15] The purpose of the
current study was to examine parental beliefs, communication and vaccine-related
health care utilization factors as potential predictors of HPV vaccination initiation
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of 11–17 year old sons. The importance of this study lies in the ability to discover
why parents choose to vaccinate their sons.
Methods
Participants
We collected web-based survey data from a U.S. national sample of parents and
legal guardians with sons 11–17 years of age (targeted age of the HPV vaccine).
Using a survey research company (Survey Sampling International or SSI), data
were drawn from U.S. adults in July and August of 2012. SSI maintains a national
panel of adults in the U.S. and facilitates access to survey respondents for market
and behavioral research. Invitations are sent at random to panel members fitting
the study protocols. Those who volunteer are then entered into a lottery to win a
monetary prize. Each panel member may participate in a maximum of four
surveys annually. The respondents’ identities remain anonymous to study
designers. Though the participants in this study were recruited nationally, they are
not a nationally-representative sample.
For this study, emails were first sent to potential participants meeting inclusion
criteria which consisted of having at least one son in the household between the
ages of 11 and 17. Only one parent per household was asked to respond regarding
only one son. Initially, 1322 panelists responded. 802 parents met eligibility
criteria and agreed to participate in the study. There were 779 surveys completed
with 758 of these respondents indicating the HPV vaccination status of their sons.
If there was more than one son meeting inclusion criteria, parents were prompted
to answer questions thinking of the youngest son in the designated age range. The
nature of this study allowed for waiving of written informed consent which, along
with study protocols, was approved by the Institutional Review Board at Indiana
University-Purdue University, Indianapolis.
Measures
The survey used for this study was designed to gather information pertaining to
parental demographics (race, age, gender, education, employment, etc.), religious
service attendance, political views, son’s health insurance and health care
utilization as well as recent influenza vaccination history and parental discussion
of sexual health topics with their sons. These specific variables were chosen for
their relationship with acceptance and initiation of HPV vaccination in prior
research. [8, 11, 12, 16–19] For HPV vaccination status, parents were asked to
indicate how many HPV shots their son had received, with responses choices of
‘‘none’’, ‘‘one’’, ‘‘two’’, or ‘‘three’’. For analysis a bivariate outcome variable was
created: no doses vaccine versus one or more doses of vaccine.
Parents reported the frequency of religious service attendance to measure how
involved they were in their particular religious organizations based on a 5-point
response scale of ‘‘rarely or never’’ to ‘‘more than once a week.’’ Parents were
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asked to describe their political views as ‘‘conservative,’’ ‘‘liberal,’’ or ‘‘middle of
the road’’ which have been shown previously to be associated with vaccine
acceptability. [8] Son’s health insurance type was chosen by parents as either
private or non-private, which included Medicaid, other state funded, self-pay,
other and unknown. Parents reported on sons’ recent healthcare utilization (i.e.,
whether or not their son was taken to a doctor, nurse, or other health care
provider in the last year) and the number of flu shots their son received in the last
2 years. Using a 4-point response format (‘‘not at all’’ to ‘‘a great deal’’), parents
also reported on the amount of time they had spent in the last 6 months
discussing sexual health topics, such as using condoms to prevent STDs, with their
sons.
Analysis
Correlations were examined among all potential independent variables to assess
for collinerarity. Logistic regression models were used to examine the outcome of
receipt of 1 or more doses of HPV vaccine. Univariable models examined each of
the behavioral and sociodemographic predictors with HPV vaccination outcome.
Predictors with significant univariable associations (defined as p,0.10) were then
included in a multivariable, adjusted model. All analyses were performed using
SPSS 21. [20] Please refer to the supplemental material for data pertinent to this
model (S1 Manuscript).
Results
Both male and female parents completed the survey and were similarly
represented at 48.5% and 51.5%, respectively. The mean age of parents
completing the survey was 42.2 years (Standard Deviation511.5). Most parents
were non-Hispanic White (73.8%), followed by non-Hispanic Black (10%),
Hispanic (9.8%), and other race/ethnicity (6.5%). Sons had a mean age of 13.8
years (Standard Deviation52.0). The majority of sons (88.5%) had seen an HCP
in the last year, and 63.8% had received at least one flu shot in the last two years.
See Table 1 for a complete description of the sample. Of the 758 parents who
provided information about their son’s HPV vaccination status, 162 (21.4%)
indicated that one or more doses of the vaccine had been administered, 73 (9.7%)
indicated that two or more doses of the vaccine had been administered and 24
(3.2%) indicated that 3 doses had been administered.
Table 2 shows the correlations among all predictors. As parent’s age increased,
their political views became more conservative (r520.12, p,0.05), their religious
service attendance increased (r50.09, p,0.05), and their sons were more likely to
have private insurance (r50.07, p,0.05). The more liberal parental political
views, the more likely they were to speak to their son regarding sexual health
(r50.07, p,0.05). The more conservative parental political views, the more likely
sons were to have private insurance (r520.10, p,0.05). As son’s age increased
Vaccinating Sons against HPV
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Table 1. Sample characteristics reported by parents (N5779)*.
Received 1 or More
Doses (N5162)
Received No
Doses (N5596)
Variable % or Mean (SD) % or Mean (SD) % or Mean (SD)
Parent gender (N5721)
Male 48.5% 47.6% 48.8%
Female 51.5% 52.4% 51.2%
Parent age in years (N5779) 42.2 (11.5) 40.0 (12.0) 42.8 (11.3)
Parent Ethnicity (N5779)
White 73.8% 63.0% 77.2%
African American 10.0% 14.8% 8.7%
Hispanic 9.8% 16.0% 7.6%
Asian 3.6% 3.1% 3.9%
Other 2.9% 3.1% 2.6%
Frequency of attendance at religious services (N5763)
Rarely or never 38.4% 35.8% 39.3%
Few times a year 18.9% 24.7% 17.1%
1–3 times a month 14.2% 13.6% 14.3%
Once a week 21.1% 16.7% 22.3%
More than once a week 7.5% 9.3% 6.9%
Political views (N5756)
Conservative 29.0% 22.0% 30.8%
Middle of the road 52.1% 57.2% 51.3%
Liberal 18.9% 20.8% 17.9%
Son’s age in years (N5779) 13.77 (1.95) 13.78 (1.88) 13.75 (1.97)
Son visited health care provider in past year (N5763)
Yes 88.5% 93.8% 87.2%
No 11.4% 6.2% 12.8%
Number of flu shots son received in past 2 years (N5759)
0 36.2% 16.5% 41.5%
1 22.4% 27.2% 20.8%
2 41.4% 56.3% 37.6%
Son’s health insurance (N5721)
Private 61.3% 50% 65%
Non-Private 38.7% 50% 35%
Frequency of discussion with son about sexual health,
such as the use of condoms to prevent STDs (N5761)
Not at all 29.3% 15.4% 33.2%
Somewhat 21.9% 16.7% 23.3%
A moderate amount 25.0% 30.2% 23.5%
A great deal 23.8% 37.7% 20.0%
Son’s HPV vaccination status (N5758)
No doses or don’t know 78.6% – –
1 or more doses 21.4% – –
*Differences in N represent missing cases.
doi:10.1371/journal.pone.0115154.t001
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there was an attendant increase in sexual health discussions with the parent
(r50.29, p,0.05) but a decrease in HCP visits (r520.11, p,0.05). These
correlations, though statistically significant, all reflected small effect sizes,
suggesting no issues of multicollinearity in multivariable analyses.
Univariable logistic regression analyses indicated that vaccine initiation was
modestly, but inversely related to parental age (OR 0.98; 95% CI 0.96–0.99). Black
(OR 2.08; 95% CI 1.23–3.53) or Hispanic (OR 2.61; 95% CI 1.54–4.42) parents
were more likely than White parents to initiate vaccination. Sons who were
evaluated by health care providers sometime in the last year more frequently
received at least one dose of the vaccine (OR 2.22; 95% CI 1.12–4.40) as did those
who had received a flu shot in the last two years (OR 1.82; 95% CI 1.45–2.26).
Son’s with private health insurance were less likely to have initiated vaccination
than those without private insurance (OR 0.55; 95% CI 0.38–0.79). There was an
association between more reported discussion of sexual health topics and greater
likelihood of first dose uptake (OR 1.61; 95% CI 1.37–1.89). Parent gender,
religiosity (measured by religious service attendance), and sons’ age were not
significant predictors of HPV vaccine initiation. Multivariable logistic regression
was performed to include all variables in the model which were significant at
p,0.10 in the univariable models. With the exception of parental age and political
views as well as son’s visit to an HCP, all significant bivariate predictors remained
independent predictors of HPV vaccine initiation in the adjusted, multivariable
model (see Table 3).
Table 2. Correlation between variables.
Variable
Parent
gender
Parent
age
Ethnic
minority
Religious
service
attendance
Political
views
Son’s
age
Visited
health care
provider
Number
of flu
shots
Son’s
health
insurance
Sexual health
discussion
Parent gender 1.00 –0.04 –0.03 –0.04 0.08* 0.04 0.09* –0.05 –0.10* –0.02
Parent age 1.00 –0.24* 0.09* –0.12* 0.21* 0.06 0.00 0.07* 0.02
Ethnic minority (15yes; 05no) 1.00 0.06 0.15* –0.03 –0.07{ 0.06 –0.15* 0.01
Frequency of religious service
attendance
1.00 –0.31* 0.01 0.05 0.04 0.05 0.03
Political views 1.00 0.02 0.00 0.05 –0.10* 0.07*
Son’s age 1.00 –0.11* –0.06 –0.00 0.29*
Son visited health care provider
in past year
1.00 0.12* 0.01 0.07{
Number of flu shots received in
past 2 years
1.00 –0.03 0.10*
Son’s health insurance 1.00 –0.03
Frequency of sexual health dis-
cussion
1.00
*p,0.05.
{p,0.10.
doi:10.1371/journal.pone.0115154.t002
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Discussion
The adolescent male vaccination rate reported by this national sample of parents
in 2012 was comparable to the 2012 NIS-TEEN data for males and females ages 13
to 17. [4] Although this set of findings indicates a marked increase from the
initiation of male vaccination in 2011, it nonetheless points to ongoing under-
immunization of the vaccine in males. Hispanic ethnicity of the parent, as well as
health care provider visit in the prior year by the son, number of flu shots received
by the son, son’s health insurance status, and frequency of discussion about sexual
health were all associated with HPV vaccine initiation.
Parent and adolescent demographics have been shown in previous research to
predict uptake of the HPV vaccine. Both conservative political views [8] and
increased religious service attendance (religiosity) [8, 9] were shown to predict
decreased vaccine uptake in females. In this study, a correlation was found
between increasing parent age and both conservative political views and
religiosity; however, none of these were associated with vaccine uptake. Son’s age
was not a predictor of vaccination uptake, a finding consistent with the 2012 NIS-
TEEN data on males. [4] In contrast, 2012 NIS-TEEN findings indicate a steady
increase in female HPV vaccination rates from 13 through 17 years of age. [4]
These findings may indicate that parents are more comfortable with vaccinating
young adolescent sons than young adolescent daughters, perhaps reflecting, a
sexual double standard, which is a well-established societal phenomenon. [21]
Parents may be more willing to vaccinate young males if the idea of emerging
male sexuality is less discomforting than emerging female sexuality. It is also
possible that HCPs are influenced by the same double standard, as research
Table 3. Factors associated with sons’ receipt of 1 or more doses of HPV vaccine.
Variable Univariate OR (95% CI) Multivariate OR (95% CI)
Parent gender 1.05 (0.73–1.52) -
Parent age 0.98 (0.96–0.99)* 0.98 (0.97–1.01)
Parent ethnicity (Non-Hispanic White 5 reference category)
Non-Hispanic Black 2.08 (1.23–3.53)* 1.46 (0.79–2.72)
Hispanic 2.61 (1.54–4.42)* 2.16 (1.16–4.01)*
Asian 0.98 (0.36–2.64) 0.71 (0.22–2.31)
Other 1.41 (0.51–3.94) 1.47 (0.44–4.90)
Religious service attendance 0.99 (0.87–1.13) -
Political views 1.28 (0.99–1.66){ 1.07 (0.80–1.44)
Son’s age 1.01 (0.92–1.10) -
Son visited health care provider in past year 2.22 (1.12–4.40)* 2.46 (1.00–6.06){
Number of flu shots son received in past 2 years 1.82 (1.45–2.26)* 1.72 (1.35–2.19)*
Son’s health insurance 0.55 (0.38–0.79)* 0.56 (0.37–0.83)*
Frequency of discussion about sexual health 1.61 (1.37–1.89)* 1.64 (1.37–1.97)*
Note: OR, odds ratio; CI, confidence interval.
*p,.05.
{p,.10.
doi:10.1371/journal.pone.0115154.t003
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suggests that frequency of HCP recommendation for HPV vaccine for females also
increases with patient age. [22] As rates of male vaccination increase, it will be
important to assess whether these differences persist, as they have implications for
gender-based health disparities. Past research has suggested that sexual double
standards have had a negative effect on women’s sexual health [21].
Consistent with our results, previous studies have found that recent influenza
vaccination is related to both acceptability and initiation of HPV vaccination.
[8, 16] Both influenza and HPV vaccination rates are relatively low compared to
other childhood/adolescent vaccines [4, 23] suggesting that both may suffer from
vaccine hesitancy on the part of parents and HCPs.
Both influenza and HPV are non-required vaccines, and parents often decline
them for a multitude of reasons. [18, 24, 25] Published research suggests that HCP
recommendation and strength of recommendation are associated with increased
HPV vaccine uptake. [12, 17, 19] HCPs who strongly recommend all vaccines, not
just those required for school, may be increasing HPV vaccination rates within
their practice. Future investigation examining the basis for the relationship
between influenza vaccine and HPV vaccination may help to clarify the nature of
this association, which in turn may have implications for clinical practice. We also
found that those sons who have private health insurance are less likely than those
without private health insurance to have initiated vaccination. Previous
publications representing data on both males and females suggest that having
public insurance is related to increased HPV vaccine initiation which may be
related to public vaccine programs such as the Vaccines for Children Program
[26, 27].
Lastly, it has been proposed that parents who are comfortable discussing sexual
health topics with their sons are more likely to engage in conversation with them
regarding HPV vaccination. [28] Since parents are, in the end, the consenting
party for those sons under age 18, this comfort level with sexual health discussion
may be a vital key to improving vaccination rates. [7, 29] Sons may have
knowledge, or specific beliefs, about HPV vaccination. By encouraging parents
and teens to have open discussions surrounding sexual health, HCPs may provide
a forum for discussion surrounding prevention of sexually transmitted infections,
and son’s may feel more comfortable expressing their beliefs about HPV
vaccination.
As in all research, there were limitations to this study. The survey participants
represented a national sample of parents of sons; however, the sample was not
nationally representative, and vaccination status was based on parental report
which has variable accuracy. [30] These issues can raise concerns regarding
generalizability. However, as noted above, the most recent NIS-TEEN data on
initiation of HPV vaccine in males is similar to the data we obtained, suggesting
that our sample did not deviate substantially from the nationally representative
NIS-TEEN sample with respect to vaccination rates [4].
This research shows sons who were exposed to healthcare services, specifically
those who had received flu shots, had an increased rate of vaccine initiation. Both
the Society for Adolescent Health and Medicine [31], and the American Academy
Vaccinating Sons against HPV
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of Pediatrics Bright Futures initiative [32] support routine provision of all
recommended vaccines for adolescents, including influenza vaccination. Our
findings suggest that HPV vaccination rates might increase by following the
practice of routinely recommending all adolescent vaccines. We would encourage
further research to examine the relationship between HCP recommendation and
receipt of these routine but non-required vaccinations. The possibility of a sexual
double standard is intriguing and deserves further investigation.
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